-
1 Comment
Guangdong Hybribio Biotech Co.,Ltd is currently in a long term downtrend where the price is trading 1.1% below its 200 day moving average.
From a valuation standpoint, the stock is 32.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.5.
Guangdong Hybribio Biotech Co.,Ltd's total revenue rose by 94.3% to $411M since the same quarter in the previous year.
Its net income has increased by 241.2% to $144M since the same quarter in the previous year.
Finally, its free cash flow grew by 618.9% to $79M since the same quarter in the previous year.
Based on the above factors, Guangdong Hybribio Biotech Co.,Ltd gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Diagnostics & Research |
| Exchange | SHE |
| CurrencyCode | CNY |
| ISIN | CNE100002N51 |
| Beta | 0.58 |
|---|---|
| Market Cap | 3B |
| PE Ratio | None |
| Target Price | 40.09 |
| Dividend Yield | 1.3% |
Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits; hearing loss susceptibility genoarray diagnostic kits; COVID-19 real-time PCR kits; and devices/instruments, including automated nucleic acid extraction, automatic medical PCR analysis, flow-through hybridization, auto DNA extraction, and fluorescent quantitative detection systems, as well as after-sales technical service support. Its products are used in the fields of national screening, clinical, and research purposes. The company operates in the Asia Pacific, the South East Asia, the Middle East, Europe, Africa, and South America. The company was founded in 2003 and is based in Chaozhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300639.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
